Chemical Industry News, Data & Insights

About Us

Home News Topics Sectors Reports Weekly Analytics

Gilead Sciences

Latest news

15 October 2025

Merck Reports Phase 3 Trial Data on Doravirine-Islatravir Regimen

Phase 3 trials show minimal weight, body composition, and lipid changes with the DOR/ISL regimen in HIV-1 patients, maintaining viral suppression without resistance.

Keep track of gilead sciences

Use chemXplore Analytics

chemXplore Analytics

The full picture, in no-time. ChemXplore Analytics empowers you with comprehensive chemical industry research tools.

Plants
Projects
Substances
News
Companies
Parks
Maps
Smart filters
Search alerts

Contact us

info@chemxplore.com

1e Pauwenlandstraat 12
7413 ZA Deventer
The Netherlands

chemXplore is a product by Darueber BV
registered at the Dutch Chamber of Commerce under number 82353735

News by sector

Basic Chemicals
Biobased & Circular
Polymers
Energy
Petrochemicals
Industrial gasses
Specialties
Textiles
CDMO
Cosmetics and Personal Care
Agrochemicals
Rubber
Pharma
Food
Feed
Construction Chemicals
Water Treatment

News types

New Projects and Expansions
Project Updates and Milestones
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Operational Changes and Investments
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management

Popular topics

Hydrogen Economy
Alternative Fuels
Circular Economy
Decarbonization Technologies
Sustainable Chemistry and Materials
Sustainable Packaging
Digital Transformation in Chemicals
Supply Chain Resilience
Advanced Materials for Technology

Top 7 substances

Hydrogen
Carbon dioxide
Natural gas
Sustainable Aviation Fuel
Polyethylene
Crude oil
Methane

Top 7 companies

BASF
TotalEnergies
Borealis
Evonik
INEOS
Eni
Siemens

Top 7 countries

Germany
United States
The Netherlands
France
Spain
Japan
China